XML 52 R37.htm IDEA: XBRL DOCUMENT v3.25.4
STOCKHOLDERS' EQUITY (Tables)
 12 Months Ended
Dec. 31, 2025
Stockholders' Equity Note [Abstract]  
Schedule of Compensation Cost on Net Earnings
The Company’s results for the years ended December 31, 2025, 2024 and 2023 reflected the following compensation cost and such compensation cost had the following effects on net earnings:
 Increase/(Decrease) for the
Year Ended December 31,
 202520242023
Cost of sales$1,643 $1,716 $1,900 
Operating expenses16,414 14,960 14,152 
Net earnings(14,100)(12,865)(12,375)
Schedule of Assumptions Used in the Valuation of Option Awards Risk-free interest rates are based on the implied yields currently available on U.S. Treasury zero coupon issues with a remaining term equal to the expected life.
Year Ended December 31,
Weighted Average Assumptions:202520242023
Expected Volatility26.0 %28.4 %28.1 %
Expected Term (in years)5.25.04.8
Risk-Free Interest Rate4.5 %4.1 %3.9 %
Dividend Yield0.6 %0.6 %0.5 %
Summary of Stock Option Activity
A summary of stock option plan activity for 2025, 2024, and 2023 for all plans is as follows:
202520242023
# of
Shares
(000s)		Weighted Average
Exercise Price		# of
Shares
(000s)		Weighted Average
Exercise Price		# of
Shares
(000s)		Weighted Average
Exercise Price
Outstanding at beginning of year962 $114.81 1,078 $104.38 1,045 $99.82 
Granted51 159.18 113 143.43 109 138.09 
Exercised(107)86.87 (221)77.81 (64)81.98 
Forfeited(5)142.00 (8)139.64 (11)131.79 
Cancelled(1)139.81 — — (1)138.07 
Outstanding at end of year900 $120.48 962 $114.81 1,078 $104.38 
Exercisable at end of year630 $109.52 603 $99.59 720 $88.49 
Schedule of Other Information Pertaining to Stock Option Activity
Other information pertaining to option activity during the years ended December 31, 2025, 2024 and 2023 is as follows:

 Years Ended December 31,
 202520242023
Weighted-average fair value of options granted$48.86 $44.52 $40.91 
Total intrinsic value of stock options exercised ($000s)$7,756 $18,631 $3,241 
Schedule of Additional Information Relating to Stock Options Outstanding
Additional information related to stock options outstanding under all plans at December 31, 2025 is as follows:

  Options OutstandingOptions Exercisable
Range of Exercise
Prices		Shares
Outstanding
(000s)		Weighted
Average
Remaining
Contractual
 Term		Weighted
Average
 Exercise
Price		Number
Exercisable
(000s)		Weighted
Average
Exercise
Price
$60.85 - $85.33
159 2.5$79.64 159 $79.64 
$85.40 - $120.60
273 3.6107.34 273 107.34 
$125.71 - $159.18
468 7.1142.06 198 136.61 
 900 5.2$120.48 630 $109.52 
Schedule of Non-vested Restricted Stock Activity
Non-vested restricted stock activity for the years ended December 31, 2025, 2024 and 2023 is summarized below:
202520242023
 Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value
Non-vested balance at beginning of year 122 $141.62 116 $133.06 122 $124.42 
Granted69 158.35 51 147.98 40 137.20 
Vested(39)138.11 (39)124.63 (42)112.30 
Forfeited(5)149.08 (6)140.70 (4)128.06 
Non-vested balance at end of year 147 $150.15 122 $141.62 116 $133.06 
Schedule of Non-vested Performance Share Activity
Non-vested performance share activity for the years ended December 31, 2025, 2024 and 2023 is summarized below:

202520242023
 Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value
Non-vested balance at beginning of year 79 $150.73 76 $135.25 70 $127.69 
Granted50 147.96 47 152.28 42 139.66 
Vested(44)130.29 (44)106.57 (36)98.84 
Forfeited(4)152.69 — — — — 
Non-vested balance at end of year 81 $160.14 79 $150.73 76 $135.25